Show simple item record

dc.contributor.authorWylie, James P
dc.contributor.authorLogue, John P
dc.date.accessioned2010-02-12T12:54:40Z
dc.date.available2010-02-12T12:54:40Z
dc.date.issued1998
dc.identifier.citationPitfalls of hCG monitoring in stage I seminoma. 1998, 10 (2):131-2 Clin Oncol (R Coll Radiol)en
dc.identifier.issn0936-6555
dc.identifier.pmid9610904
dc.identifier.doi10.1016/S0936-6555(05)80495-9
dc.identifier.urihttp://hdl.handle.net/10541/91980
dc.description.abstractWe detail the case history of a patient with Stage I seminoma, who developed an elevated level of human chorionic gonadotrophin (hCG) while on follow-up. It transpired that the patient had injected himself with hCG several days before. This type of abuse has been documented, but this is the first reported case of it interfering with the follow-up of a patient with a germ cell tumour.
dc.language.isoenen
dc.subjectBiological Tumour Markersen
dc.subjectTesticular Canceren
dc.subject.meshAdult
dc.subject.meshChorionic Gonadotropin
dc.subject.meshDiagnosis, Differential
dc.subject.meshHumans
dc.subject.meshMale
dc.subject.meshSelf Medication
dc.subject.meshSeminoma
dc.subject.meshTesticular Neoplasms
dc.subject.meshTumor Markers, Biological
dc.titlePitfalls of hCG monitoring in stage I seminoma.en
dc.typeArticleen
dc.contributor.departmentChristie Hospital NHS Trust, Withington, Manchester, UK.en
dc.identifier.journalClinical Oncologyen
html.description.abstractWe detail the case history of a patient with Stage I seminoma, who developed an elevated level of human chorionic gonadotrophin (hCG) while on follow-up. It transpired that the patient had injected himself with hCG several days before. This type of abuse has been documented, but this is the first reported case of it interfering with the follow-up of a patient with a germ cell tumour.


Files in this item

This item appears in the following Collection(s)

Show simple item record